Preconceptional Maternal Hyperandrogenism and Metabolic Syndrome Risk in Male Offspring: a Long-term Population-based Study

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2024 Apr 22

PMID 38647948

Authors

M Noroozzadeh

M Rahmati

M Amiri

M Saei Ghare Naz

F Azizi

F Ramezani Tehrani

Affiliations

Soon will be listed here.

Abstract

Purpose: There is limited research on the effects of maternal hyperandrogenism (MHA) on cardiometabolic risk factors in male offspring. We aimed to compare the risk of metabolic syndrome (MetS) in sons of women with preconceptional hyperandrogenism (HA) to those of non-HA women in later life.

Methods: Using data obtained from the Tehran Lipid and Glucose Cohort Study, with an average of 20 years follow-up, 1913 sons were divided into two groups based on their MHA status, sons with MHA (n = 523) and sons without MHA (controls n = 1390). The study groups were monitored from the baseline until either the incidence of events, censoring, or the end of the study period, depending on which occurred first. Age-scaled unadjusted and adjusted Cox regression models were utilized to evaluate the hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between MHA and MetS in their sons.

Results: There was no significant association between MHA and HR of MetS in sons with MHA compared to controls, even after adjustment (unadjusted HR (95% CI) 0.94 (0.80-1.11), P = 0.5) and (adjusted HR (95% CI) 0.98 (0.81-1.18), P = 0.8). Sons with MHA showed a HR of 1.35 for developing high fasting blood sugar compared to controls (unadjusted HR (95% CI) 1.35 (1.01-1.81), P = 0.04), however, after adjustment this association did not remain significant (adjusted HR (95% CI) 1.25 (0.90-1.74), P = 0.1).

Conclusion: The results suggest that preconceptional MHA doesn't increase the risk of developing MetS in sons in later life. According to this suggestion, preconceptional MHA may not have long-term metabolic consequences in male offspring.

References

Naseri P, Khodakarim S, Guity K, Daneshpour M . Familial aggregation and linkage analysis with covariates for metabolic syndrome risk factors. Gene. 2018; 659:118-122. DOI: 10.1016/j.gene.2018.03.033. View

Ramirez-Velez R . [In utero fetal programming and its impact on health in adulthood]. Endocrinol Nutr. 2012; 59(6):383-93. DOI: 10.1016/j.endonu.2012.02.002. View

Roland A, Nunemaker C, Keller S, Moenter S . Prenatal androgen exposure programs metabolic dysfunction in female mice. J Endocrinol. 2010; 207(2):213-23. PMC: 3612271. DOI: 10.1677/JOE-10-0217. View

Sherman S, Sarsour N, Salehi M, Schroering A, Mell B, Joe B . Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis. Gut Microbes. 2018; 9(5):400-421. PMC: 6219642. DOI: 10.1080/19490976.2018.1441664. View

Noroozzadeh M, Rahmati M, Behboudi-Gandevani S, Ramezani Tehrani F . Maternal hyperandrogenism is associated with a higher risk of type 2 diabetes mellitus and overweight in adolescent and adult female offspring: a long-term population-based follow-up study. J Endocrinol Invest. 2022; 45(5):963-972. DOI: 10.1007/s40618-021-01721-2. View

Noroozzadeh M, Rahmati M, Farhadi-Azar M, Saei Ghare Naz M, Azizi F, Ramezani Tehrani F . Maternal androgen excess increases the risk of metabolic syndrome in female offspring in their later life: A long-term population-based follow-up study. Arch Gynecol Obstet. 2023; 308(5):1555-1566. DOI: 10.1007/s00404-023-07132-3. View

Puttabyatappa M, Padmanabhan V . Prenatal Testosterone Programming of Insulin Resistance in the Female Sheep. Adv Exp Med Biol. 2017; 1043:575-596. DOI: 10.1007/978-3-319-70178-3_25. View

Manti M, Fornes R, Pironti G, McCann Haworth S, Zhengbing Z, Benrick A . Maternal androgen excess induces cardiac hypertrophy and left ventricular dysfunction in female mice offspring. Cardiovasc Res. 2019; 116(3):619-632. DOI: 10.1093/cvr/cvz180. View

Ramezani Tehrani F, Behboudi-Gandevani S, Rostami Dovom M, Farahmand M, Minooee S, Noroozzadeh M . Reproductive Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018; 16(4 Suppl):e84786. PMC: 6289318. DOI: 10.5812/ijem.84786. View

10.

Ramezani Tehrani F, Rashidi H, Azizi F . The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reprod Biol Endocrinol. 2011; 9:144. PMC: 3214199. DOI: 10.1186/1477-7827-9-144. View

11.

Asghari G, Yuzbashian E, Mirmiran P, Hooshmand F, Najafi R, Azizi F . Dietary Approaches to Stop Hypertension (DASH) Dietary Pattern Is Associated with Reduced Incidence of Metabolic Syndrome in Children and Adolescents. J Pediatr. 2016; 174:178-184.e1. DOI: 10.1016/j.jpeds.2016.03.077. View

12.

Griffin B, Anderson G, Shih R, Whitsel E . Use of alternative time scales in Cox proportional hazard models: implications for time-varying environmental exposures. Stat Med. 2012; 31(27):3320-7. PMC: 3468711. DOI: 10.1002/sim.5347. View

13.

Zhang Z . Multiple imputation for time series data with Amelia package. Ann Transl Med. 2016; 4(3):56. PMC: 4740012. DOI: 10.3978/j.issn.2305-5839.2015.12.60. View

14.

Ozanne S . Metabolic programming in animals. Br Med Bull. 2002; 60:143-52. DOI: 10.1093/bmb/60.1.143. View

15.

Goldstein J, Hale T, Foster S, Tobet S, Handa R . Sex differences in major depression and comorbidity of cardiometabolic disorders: impact of prenatal stress and immune exposures. Neuropsychopharmacology. 2018; 44(1):59-70. PMC: 6235859. DOI: 10.1038/s41386-018-0146-1. View

16.

Rinaudo P, Wang E . Fetal programming and metabolic syndrome. Annu Rev Physiol. 2011; 74:107-30. PMC: 4132057. DOI: 10.1146/annurev-physiol-020911-153245. View

17.

Osmond C, Barker D . Ischaemic heart disease in England and Wales around the year 2000. J Epidemiol Community Health. 1991; 45(1):71-2. PMC: 1060705. DOI: 10.1136/jech.45.1.71. View

18.

Stavreva D, George A, Klausmeyer P, Varticovski L, Sack D, Voss T . Prevalent glucocorticoid and androgen activity in US water sources. Sci Rep. 2012; 2:937. PMC: 3515810. DOI: 10.1038/srep00937. View

19.

Hakim C, Padmanabhan V, Vyas A . Gestational Hyperandrogenism in Developmental Programming. Endocrinology. 2016; 158(2):199-212. PMC: 5413081. DOI: 10.1210/en.2016-1801. View

20.

Padmanabhan V, Manikkam M, Recabarren S, Foster D . Prenatal testosterone excess programs reproductive and metabolic dysfunction in the female. Mol Cell Endocrinol. 2006; 246(1-2):165-74. DOI: 10.1016/j.mce.2005.11.016. View